Literature DB >> 10383516

Review article: the management of Giardiasis.

C J Vesy1, W L Peterson.   

Abstract

Giardiasis is the intestinal infection resulting from infestation with the human parasite Giardia intestinalis, also called Giardia lamblia. The infection may be asymptomatic or present with a variety of symptoms such as diarrhoea, weight loss, abdominal cramps, and failure to thrive. Giardiasis is most often diagnosed after recent travel or in day care centres. The organism has two stages in its life cycle. It is usually ingested as a cyst with as few as 10-25 cysts being sufficient to cause infection. After excystation, the organism is a replicative trophozoite which may attach to the small bowel wall. Giardia intestinalis does not invade the bowel wall. Trophozoites may encyst and be shed in faeces for future ingestion by another host. Diagnosis of infection is by stool examination which may also eliminate other possible infectious agents. Small bowel biopsy may be necessary in difficult individual cases or to rule out non-infectious illnesses, and stool ELISA may serve for large population screening examinations. The mainstay of treatment is metronidazole 250-400 mg three times per day by mouth for 5 days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383516     DOI: 10.1046/j.1365-2036.1999.00537.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

1.  Eosinophilic gastroenteritis: review of the literature.

Authors:  Julian E Losanoff; Edward R Sauter
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

Review 2.  Management of infectious diarrhoea.

Authors:  A C Casburn-Jones; M J G Farthing
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

3.  Chronic diarrhoea.

Authors:  R Spiller
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 4.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata.

Authors:  Therese Moon; Jenny M Wilkinson; Heather M A Cavanagh
Journal:  Parasitol Res       Date:  2006-06-02       Impact factor: 2.289

6.  Does co-infection with Giardia lamblia modulate the clinical characteristics of enteric infections in young children?

Authors:  Natalya Bilenko; Amalya Levy; Ron Dagan; Richard J Deckelbaum; Yossef El-On; Drora Fraser
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.

Authors:  Joshua A Kramer; Audra M Hachey; Lynn M Wachtman; Keith G Mansfield
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

8.  Giardia lamblia: a report of drug effects under cell differentiation.

Authors:  Moema A Hausen; Richard Pereira de Oliveira; Ana Paula Rocha Gadelha; Loraine Campanati; Jorge José de Carvalho; Laís de Carvalho; Helene Santos Barbosa
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

9.  Diagnostic yield of duodenal aspirate for G. lamblia and comparison to duodenal mucosal biopsies.

Authors:  Sandeep K Gupta; Joseph M Croffie; Marian D Pfefferkorn; Joseph F Fitzgerald
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

10.  Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study.

Authors:  Oguz Karabay; Ali Tamer; Huseyin Gunduz; Derya Kayas; Huseyin Arinc; Harika Celebi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.